We are live on ! Find out more
HRMY icon

Harmony Biosciences
HRMY

182 hedge funds and large institutions have $2.21B invested in Harmony Biosciences in 2022 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 76 increasing their positions, 42 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 10

81% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 42

25% more funds holding in top 10

Funds holding in top 10: 8 → 10 (+2)

24% more funds holding

Funds holding: 147 → 182 (+35)

16% more capital invested

Capital invested by funds: $1.9B → $2.21B (+$310M)

2.16% more ownership

Funds ownership: 76.21% → 78.38% (+2.2%)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $224K

Holders
182
Holders Change
+35
Holders Change %
+23.81%
% of All Funds
2.87%
Holding in Top 10
10
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+25%
% of All Funds
0.16%
New
45
Increased
76
Reduced
42
Closed
10
Calls
–
Puts
$224K
Net Calls
-$224K
Net Calls Change
-$224K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$28.1M
2
PCH
Polar Capital Holdings
United Kingdom
+$22.4M
3
Macquarie Group
Macquarie Group
Australia
+$16.5M
4
TCM
Tang Capital Management
California
+$12.2M
5
HRCM
Hood River Capital Management
Florida
+$12.2M

Top Sellers

Rank Fund Capital Flow
1
VP
venBio Partners
California
-$48.8M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$25.2M
3
VC
Vivo Capital
California
-$12.8M
4
PA
Perceptive Advisors
New York
-$10.2M
5
NP
Newlight Partners
New York
-$10.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
176
Perceptive Advisors
New York
– -$10.2M -239,258 Closed
PAMP
177
Polar Asset Management Partners
Ontario, Canada
– -$2.2M -51,600 Closed
MFS
178
Mirabella Financial Services
United Kingdom
– -$1.58M -37,083 Closed
Schroder Investment Management Group
179
Schroder Investment Management Group
United Kingdom
– -$1.43M -33,469 Closed
ECM
180
ExodusPoint Capital Management
New York
– -$381K -8,936 Closed
WG
181
Winton Group
United Kingdom
– -$296K -6,932 Closed
Rafferty Asset Management
182
Rafferty Asset Management
New York
– -$281K -6,585 Closed
SGAM
183
Smith Group Asset Management
Texas
– -$17K -400 Closed
EVM
184
Eaton Vance Management
Massachusetts
– -$16K -366 Closed
SIC
185
SJS Investment Consulting
Ohio
– +$41 +1 New
SOW
186
State of Wyoming
Wyoming
– +$41 +1 +14%
DI
187
Disciplined Investments
Oklahoma
– +$82 +2 New
SC
188
Schubert & Co
Texas
– +$122 +3 +300%
AF
189
Allworth Financial
California
– +$245 +6 New
CI
190
Cordant Inc
Oregon
– +$245 +6 New
JWA
191
JFS Wealth Advisors
Pennsylvania
– +$245 +6 +600%
4 5 6 7
8

HRMY Hedge Fund Activity: Q1 2022 in Review

182 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Harmony Biosciences (HRMY) for Q1 2022, worth a combined $2.21B — up 16% from $1.9B a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new HRMY positions and 10 closed out — a net gain of 35 holders — while 76 added to existing stakes and 42 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $28.1M. The largest seller was venBio Partners, cutting an estimated $48.8M.

  • 182 institutional investors held Harmony Biosciences (HRMY) as of Q1 2022, up from 147 in Q4 2021.
  • Funds reported $2.21B of Harmony Biosciences stock for Q1 2022, up 16% quarter-over-quarter.
  • 45 funds opened new Harmony Biosciences positions in Q1 2022 and 10 closed out, a net change of +35 holders.
  • The largest Harmony Biosciences buyer in Q1 2022 was Fidelity Investments, an estimated $28.1M added.
  • The largest Harmony Biosciences seller in Q1 2022 was venBio Partners, an estimated $48.8M sold.

Based on aggregated 13F filings for Q1 2022.